Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2022-03-07 02:49:06 UTC |
---|
HMDB ID | HMDB0000795 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Pristanic acid |
---|
Description | Pristanic acid (2,6,10,14-tetramethylpentadecanoic acid) is a terpenoid acid present at micromolar concentrations in the plasma of healthy individuals. It is also found in the lipids from many sources such as freshwater sponges, krill, earthworms, whales, human milk fat, bovine depot fat, butterfat or Californian petroleum. It is usually present in combination with phytanic acid. In humans, pristanic acid is obtained from two sources: either directly from the diet or as the alpha oxidation product of phytanic acid. At physiological concentrations pristanic acid is a natural ligand for PPARalpha. In liver, pristanic acid is degraded by peroxisomal beta oxidation to propionyl-CoA. Together with phytanic acid, pristanic acid accumulates in several inherited disorders such as Zellweger syndrome. Pristanic acid is a branched chain fatty acid that arises from the breakdown of phytanic acid. It is present at micromolar concentrations in the plasma of healthy individuals. Pristanic acid is normally degraded by peroxisomal beta-oxidation. In patients affected with generalized peroxisomal disorders, degradation of both phytanic acid and pristanic acid is impaired owing to absence of functional peroxisomes. Pristanic acid has been found to activate the peroxisome proliferator-activated receptor {alpha} (PPAR{alpha}) in a concentration dependent manner. |
---|
Structure | CC(C)CCCC(C)CCCC(C)CCCC(C)C(O)=O InChI=1S/C19H38O2/c1-15(2)9-6-10-16(3)11-7-12-17(4)13-8-14-18(5)19(20)21/h15-18H,6-14H2,1-5H3,(H,20,21) |
---|
Synonyms | Value | Source |
---|
2,6,10,14-Tetramethyl-pentadecansaeure | ChEBI | 2,6,10,14-Tetramethylpentadecylic acid | ChEBI | Acide pristanique | ChEBI | Acido pristanico | ChEBI | Pristaninsaeure | ChEBI | 2,6,10,14-Tetramethylpentadecylate | Generator | Pristanate | Generator | (2S)-Pristanic acid | HMDB | (2S,6R,10R)-2,6,10,14-Tetramethylpentadecanoate | HMDB | (2S,6R,10R)-2,6,10,14-Tetramethylpentadecanoic acid | HMDB | (2S,6R,10R)-Pristanic acid | HMDB | 2,6,10,14-Tetramethylpentadecanoate | HMDB | 2,6,10,14-Tetramethylpentadecanoic acid | HMDB | Pristanate:(2S,6R,10R)-pristanate | HMDB |
|
---|
Chemical Formula | C19H38O2 |
---|
Average Molecular Weight | 298.511 |
---|
Monoisotopic Molecular Weight | 298.287180464 |
---|
IUPAC Name | 2,6,10,14-tetramethylpentadecanoic acid |
---|
Traditional Name | pristanic acid |
---|
CAS Registry Number | 1189-37-3 |
---|
SMILES | CC(C)CCCC(C)CCCC(C)CCCC(C)C(O)=O |
---|
InChI Identifier | InChI=1S/C19H38O2/c1-15(2)9-6-10-16(3)11-7-12-17(4)13-8-14-18(5)19(20)21/h15-18H,6-14H2,1-5H3,(H,20,21) |
---|
InChI Key | PAHGJZDQXIOYTH-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as acyclic diterpenoids. These are diterpenoids (compounds made of four consecutive isoprene units) that do not contain a cycle. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Prenol lipids |
---|
Sub Class | Diterpenoids |
---|
Direct Parent | Acyclic diterpenoids |
---|
Alternative Parents | |
---|
Substituents | - Acyclic diterpenoid
- Long-chain fatty acid
- Methyl-branched fatty acid
- Branched fatty acid
- Fatty acyl
- Fatty acid
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Not Available | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.0035 mg/L @ 25 °C (est) | The Good Scents Company Information System | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatized |
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Pristanic acid GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-9870000000-f2a1fccf594927bf2658 | 2017-07-27 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Pristanic acid GC-MS (1 TMS) - 70eV, Positive | splash10-05g0-9432000000-dff09e9ff5d30894796a | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Pristanic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Pristanic acid GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Pristanic acid Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-06si-4940000000-03beff6ee7e5712b0be3 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pristanic acid Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-052r-2900000000-257d1f0711d1a7f28338 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pristanic acid Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-00xr-5932000000-d9475b731502d4745a32 | 2012-07-24 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pristanic acid 10V, Positive-QTOF | splash10-0002-0190000000-9f7f32c22384a93f6bdb | 2017-06-28 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pristanic acid 20V, Positive-QTOF | splash10-0kdj-6960000000-7187029bd8b4d1886bf6 | 2017-06-28 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pristanic acid 40V, Positive-QTOF | splash10-0a6s-9810000000-051a9ebc7e20e03dd488 | 2017-06-28 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pristanic acid 10V, Negative-QTOF | splash10-0002-0090000000-2e296a53a5e430402f60 | 2017-06-28 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pristanic acid 20V, Negative-QTOF | splash10-0f6t-0090000000-ae75aba02491d467a13d | 2017-06-28 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pristanic acid 40V, Negative-QTOF | splash10-059i-9480000000-ef08cae03dc3995f91f5 | 2017-06-28 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pristanic acid 10V, Positive-QTOF | splash10-0002-2290000000-23db43d16b6195905dda | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pristanic acid 20V, Positive-QTOF | splash10-07li-9620000000-5c45c02dd25695e1c91b | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pristanic acid 40V, Positive-QTOF | splash10-0a4i-9000000000-be260050b449f341bc60 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pristanic acid 10V, Negative-QTOF | splash10-0002-0090000000-d78513c03955a860495d | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pristanic acid 20V, Negative-QTOF | splash10-0002-0090000000-b72f0143bca09dec99f9 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pristanic acid 40V, Negative-QTOF | splash10-0007-7690000000-4162e1382b3a0cd64736 | 2021-09-24 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | 2022-08-20 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | - Cytoplasm
- Extracellular
- Membrane (predicted from logP)
- Peroxisome
|
---|
Biospecimen Locations | |
---|
Tissue Locations | - Fibroblasts
- Neuron
- Prostate
|
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | <3.000 uM | Adult (>18 years old) | Male | Normal | | details | Blood | Detected and Quantified | 0-3.350 uM | Children (1-13 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 1.5 (0.0-3.0) uM | Newborn (0-30 days old) | Both | Adrenoleukodystrophy, neonatal | | details | Blood | Detected and Quantified | 105 uM | Adult (>18 years old) | Male | Alpha-Methylacyl-CoA racemase deficiency | | details | Blood | Detected and Quantified | 0.61 uM | Newborn (0-30 days old) | Female | Rhizomelic chondrodysplasia punctata | | details | Blood | Detected and Quantified | 4.24 uM | Infant (0-1 year old) | Male | Peroxisomal biogenesis disorder | | details | Blood | Detected and Quantified | 27.6 uM | Newborn (0-30 days old) | Not Specified | Zellweger syndrome | | details | Blood | Detected and Quantified | 68.6 uM | Newborn (0-30 days old) | Not Specified | Neonatal adrenoleukodystrophy | | details | Blood | Detected and Quantified | 1.0100-51.960 uM | Children (1-13 years old) | Female | Peroxisomal biogenesis disorder | | details | Blood | Detected and Quantified | 16.100-24.800 uM | Newborn (0-30 days old) | Female | Peroxisomal biogenesis disorder | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Adrenoleukodystrophy, neonatal |
---|
- G.Frauendienst-Egger, Friedrich K. Trefz (2017). MetaGene: Metabolic & Genetic Information Center (MIC: http://www.metagene.de). METAGENE consortium.
| Rhizomelic chondrodysplasia punctata |
---|
- Baumgartner MR, Poll-The BT, Verhoeven NM, Jakobs C, Espeel M, Roels F, Rabier D, Levade T, Rolland MO, Martinez M, Wanders RJ, Saudubray JM: Clinical approach to inherited peroxisomal disorders: a series of 27 patients. Ann Neurol. 1998 Nov;44(5):720-30. [PubMed:9818927 ]
| Peroxisomal biogenesis defect |
---|
- Baumgartner MR, Poll-The BT, Verhoeven NM, Jakobs C, Espeel M, Roels F, Rabier D, Levade T, Rolland MO, Martinez M, Wanders RJ, Saudubray JM: Clinical approach to inherited peroxisomal disorders: a series of 27 patients. Ann Neurol. 1998 Nov;44(5):720-30. [PubMed:9818927 ]
| Alpha-Methylacyl-CoA racemase deficiency |
---|
- McLean BN, Allen J, Ferdinandusse S, Wanders RJ: A new defect of peroxisomal function involving pristanic acid: a case report. J Neurol Neurosurg Psychiatry. 2002 Mar;72(3):396-9. [PubMed:11861706 ]
|
|
---|
Associated OMIM IDs | - 215100 (Rhizomelic chondrodysplasia punctata)
- 214100 (Peroxisomal biogenesis defect)
- 614307 (Alpha-Methylacyl-CoA racemase deficiency)
|
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB012993 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 110458 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | PRISTANATE |
---|
BiGG ID | 2364527 |
---|
Wikipedia Link | Pristanic acid |
---|
METLIN ID | 5760 |
---|
PubChem Compound | 123929 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 51340 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | PRIST |
---|
MarkerDB ID | MDB00000255 |
---|
Good Scents ID | rw1489071 |
---|
References |
---|
Synthesis Reference | Nakajima, Kenji; Sato, Akio. Microbial oxidation of isoprenoid hydrocarbons. Part II. Production of pristanol and pristanic acid from pristane by Nocardia sp. BPM 1613. Nippon Nogei Kagaku Kaishi (1981), 55(9), 825-8. |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Wanders RJ, Barth PG, Schutgens RB, Tager JM: Clinical and biochemical characteristics of peroxisomal disorders: an update. Eur J Pediatr. 1994;153(7 Suppl 1):S44-8. [PubMed:7957386 ]
- Mobley JA, Leav I, Zielie P, Wotkowitz C, Evans J, Lam YW, L'Esperance BS, Jiang Z, Ho SM: Branched fatty acids in dairy and beef products markedly enhance alpha-methylacyl-CoA racemase expression in prostate cancer cells in vitro. Cancer Epidemiol Biomarkers Prev. 2003 Aug;12(8):775-83. [PubMed:12917210 ]
- Ferdinandusse S, Denis S, IJlst L, Dacremont G, Waterham HR, Wanders RJ: Subcellular localization and physiological role of alpha-methylacyl-CoA racemase. J Lipid Res. 2000 Nov;41(11):1890-6. [PubMed:11060359 ]
- Straube R, Gackler D, Thiele A, Muselmann L, Kingreen H, Klingel R: Membrane differential filtration is safe and effective for the long-term treatment of Refsum syndrome--an update of treatment modalities and pathophysiological cognition. Transfus Apher Sci. 2003 Aug;29(1):85-91. [PubMed:12877898 ]
- Verhoeven NM, Kulik W, van den Heuvel CM, Jakobs C: Pre- and postnatal diagnosis of peroxisomal disorders using stable-isotope dilution gas chromatography--mass spectrometry. J Inherit Metab Dis. 1995;18 Suppl 1:45-60. [PubMed:9053555 ]
- Ferdinandusse S, Kostopoulos P, Denis S, Rusch H, Overmars H, Dillmann U, Reith W, Haas D, Wanders RJ, Duran M, Marziniak M: Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy. Am J Hum Genet. 2006 Jun;78(6):1046-52. Epub 2006 Mar 29. [PubMed:16685654 ]
- Gootjes J, Mooijer PA, Dekker C, Barth PG, Poll-The BT, Waterham HR, Wanders RJ: Biochemical markers predicting survival in peroxisome biogenesis disorders. Neurology. 2002 Dec 10;59(11):1746-9. [PubMed:12473763 ]
- Zomer AW, van Der Burg B, Jansen GA, Wanders RJ, Poll-The BT, van Der Saag PT: Pristanic acid and phytanic acid: naturally occurring ligands for the nuclear receptor peroxisome proliferator-activated receptor alpha. J Lipid Res. 2000 Nov;41(11):1801-7. [PubMed:11060349 ]
|
---|